Patients with MSA present with a combination of cerebellar dysfunction, parkinsonism, and autonomic dysfunction and are pathologically characterized by alpha-synuclein immunoreactive glial cytoplasmic inclusions and neuronal loss in the olivopontocerebellar and striatonigral systems (Ahmed et al., 2012). The gene discussed is SNCA; the disease is multiple system atrophy.